SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-19-007552
Filing Date
2019-06-21
Accepted
2019-06-21 17:23:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(3) azrx_424b3.htm 424B3 207254
2 IMAGE azurrx_logo000.jpg GRAPHIC 6140
  Complete submission text file 0001654954-19-007552.txt   216916
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B3 | Act: 33 | File No.: 333-231035 | Film No.: 19912457
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1